pyrroles has been researched along with zatebradine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiba, S; Furukawa, Y; Inoue, Y; Sawaki, S; Takayama, S | 1 |
Grenett, HE; Huang, J; Ku, DD; Urthaler, F; Wolkowicz, PE; Wu, HC | 1 |
2 other study(ies) available for pyrroles and zatebradine
Article | Year |
---|---|
A bradycardic agent, UL-FS 49, increases atrial force and decreases ventricular force in isolated, perfused heart preparations of dogs.
Topics: Acetylcholine; Adenosine; Animals; Atrial Function; Benzazepines; Benzopyrans; Cardiovascular Agents; Cromakalim; Dogs; Heart Atria; Heart Ventricles; In Vitro Techniques; Myocardial Contraction; Perfusion; Potassium Channels; Pyrroles; Sinoatrial Node; Ventricular Function | 1993 |
A pharmacological model for calcium overload-induced tachycardia in isolated rat left atria.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzazepines; Boron Compounds; Calcium; Calcium Channel Agonists; Cardiotonic Agents; Cyclic Nucleotide-Gated Cation Channels; Heart Atria; In Vitro Techniques; Male; Ouabain; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ryanodine; Tachycardia | 2007 |